Trial · NCT00878189
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | PF-03084014 20 mg BID in Solid Tumor Participants | 3 | |
| Overall Study | STARTED | PF-03084014 40 mg BID in Solid Tumor Participants | 3 | |
| Overall Study | STARTED | PF-03084014 80 mg BID in Solid Tumor Participants | 4 | |
| Overall Study | STARTED | PF-03084014 100 mg BID in Solid Tumor Participants | 8 | |
| Overall Study | STARTED | PF-03084014 130 mg BID in Solid Tumor Participants | 4 | |
| Overall Study | STARTED | PF-03084014 150 mg BID in Solid Tumor Participants | 23 | |
| Overall Study | STARTED | PF-03084014 220 mg BID in Solid Tumor Participants | 16 | |
| Overall Study | STARTED | PF-03084014 330 mg BID in Solid Tumor Participants | 3 | |
| Overall Study | STARTED | PF-03084014 150 mg BID in T-ALL/LBL Participants | 8 | |
| Overall Study | COMPLETED | PF-03084014 20 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 40 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 80 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 100 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 130 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 150 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 220 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 330 mg BID in Solid Tumor Participants | 0 | |
| Overall Study | COMPLETED | PF-03084014 150 mg BID in T-ALL/LBL Participants | 0 | |
| Overall Study | NOT COMPLETED | PF-03084014 20 mg BID in Solid Tumor Participants | 3 | |
| Overall Study | NOT COMPLETED | PF-03084014 40 mg BID in Solid Tumor Participants | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00878189/flow